The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
2020-09-24T06:30:00+01:00Commissioned by Bayer plc
Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines for Pharmacy. Please see the bottom of the page for full disclaimer.
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.